289 related articles for article (PubMed ID: 31121307)
1. Estrogen receptor alpha regulates the Wnt/β-catenin signaling pathway in colon cancer by targeting the NOD-like receptors.
Liu S; Fan W; Gao X; Huang K; Ding C; Ma G; Yan L; Song S
Cell Signal; 2019 Sep; 61():86-92. PubMed ID: 31121307
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptors participate in carcinogenesis signaling pathways by directly regulating NOD-like receptors.
Fan W; Gao X; Ding C; Lv Y; Shen T; Ma G; Yan L; Song S
Biochem Biophys Res Commun; 2019 Apr; 511(2):468-475. PubMed ID: 30797557
[TBL] [Abstract][Full Text] [Related]
3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
4. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
5. Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells.
Hsu HH; Cheng SF; Chen LM; Liu JY; Chu CH; Weng YJ; Li ZY; Lin CS; Lee SD; Kuo WW; Huang CY
Mol Cell Biochem; 2006 Sep; 289(1-2):101-9. PubMed ID: 16628468
[TBL] [Abstract][Full Text] [Related]
6. A DNA binding mutation in estrogen receptor-α leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts.
Mödder UI; Rudnik V; Liu G; Khosla S; Monroe DG
J Cell Biochem; 2012 Jul; 113(7):2248-55. PubMed ID: 22573547
[TBL] [Abstract][Full Text] [Related]
7. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
[TBL] [Abstract][Full Text] [Related]
8. Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice.
Cleveland AG; Oikarinen SI; Bynoté KK; Marttinen M; Rafter JJ; Gustafsson JA; Roy SK; Pitot HC; Korach KS; Lubahn DB; Mutanen M; Gould KA
Carcinogenesis; 2009 Sep; 30(9):1581-90. PubMed ID: 19520794
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Breast Cancer Preventive Action of Pomegranate: Disruption of Estrogen Receptor and Wnt/β-Catenin Signaling Pathways.
Mandal A; Bishayee A
Molecules; 2015 Dec; 20(12):22315-28. PubMed ID: 26703530
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MINCR aggravates colon cancer via regulating miR-708-5p-mediated Wnt/β-catenin pathway.
Yu Y; Chang Z; Han C; Zhuang L; Zhou C; Qi X; Peng Z
Biomed Pharmacother; 2020 Sep; 129():110292. PubMed ID: 32535381
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous disruption of estrogen receptor and Wnt/β-catenin signaling is involved in methyl amooranin-mediated chemoprevention of mammary gland carcinogenesis in rats.
Mandal A; Bhatia D; Bishayee A
Mol Cell Biochem; 2013 Dec; 384(1-2):239-50. PubMed ID: 24078029
[TBL] [Abstract][Full Text] [Related]
13. Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling.
Takahashi K; Hosono M; Sato I; Hata K; Wada T; Yamaguchi K; Nitta K; Shima H; Miyagi T
Int J Cancer; 2015 Oct; 137(7):1560-73. PubMed ID: 25810027
[TBL] [Abstract][Full Text] [Related]
14. ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways.
Singh S; Arcaroli J; Chen Y; Thompson DC; Messersmith W; Jimeno A; Vasiliou V
PLoS One; 2015; 10(5):e0121648. PubMed ID: 25950950
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive microRNA-145 targets catenin δ-1 to regulate Wnt/β-catenin signaling in human colon cancer cells.
Yamada N; Noguchi S; Mori T; Naoe T; Maruo K; Akao Y
Cancer Lett; 2013 Jul; 335(2):332-42. PubMed ID: 23499891
[TBL] [Abstract][Full Text] [Related]
16. Multilevel regulation of Wnt signaling by Zic2 in colon cancer due to mutation of β-catenin.
Xu Z; Zheng J; Chen Z; Guo J; Li X; Wang X; Qu C; Yuan L; Cheng C; Sun X; Yu J
Cell Death Dis; 2021 Jun; 12(6):584. PubMed ID: 34099631
[TBL] [Abstract][Full Text] [Related]
17. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
[TBL] [Abstract][Full Text] [Related]
19. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
20. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.
Ahmad R; Kumar B; Chen Z; Chen X; Müller D; Lele SM; Washington MK; Batra SK; Dhawan P; Singh AB
Oncogene; 2017 Nov; 36(47):6592-6604. PubMed ID: 28783170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
